In fact, a clinical trial is presently recruiting DMD patients to study endomysial fibrosis, deregulated inflammatory responses and Ca2+ influx dysfunction in order to better understand the relationship between each secondary pathology in dystrophin-deficient humans (ClinicalTrials.gov, trial NCT01823783). Here, DMD is linked to Duchenne muscular dystrophy.